{"schema_version":"secwatch.filing_event.v1","accession":"0001722482-22-000162","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.810131+00:00","generated_at":"2026-06-24T07:37:02.065661+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Avantor Q2 beats: EPS $0.37 adjusted, revenue $1.91B, core organic growth 6.4%","bullets":["Net sales $1.91B (+2.8% reported; core organic +6.4%); adjusted EBITDA $404.1M (+10.2%), margin 21.2% (+140bps).","Diluted GAAP EPS $0.28, adjusted EPS $0.37; net income $187.4M vs $157.8M prior year.","Operating cash flow $227.5M, free cash flow $191.2M; adjusted net leverage reduced to 3.9X.","Americas core organic +8.1%, Europe +4.7%, AMEA -0.3%; segment EBITDA margins all improved.","CEO cites strong bioproduction growth (+20% core organic) and expects continued momentum in H2."],"urls":{"canonical":"https://secwatch.observer/filing/0001722482-22-000162","json":"https://secwatch.observer/filing/0001722482-22-000162.json","markdown":"https://secwatch.observer/filing/0001722482-22-000162.md","text":"https://secwatch.observer/filing/0001722482-22-000162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000172248222000162/0001722482-22-000162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000172248222000162/avtr-20220728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:37:02.065661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}